EN 
JA GREETING
Greetings from the Representative
suffer from heart failure
Many patients with dilated cardiomyopathyindicates such things as location of person or thing, location of short-term action, etc.
I want them to be able to do normal exercise and daily activities.
The iCorNet Research Institute, Inc. began when I chose "treatment methods for heart failure patients" as my research topic when I arrived at my alma mater, Nagoya University School of Medicine, as a lecturer.
At the time, there were several treatments for heart failure and dilated cardiomyopathy, but none were "for older patients who need treatment the most" or "relatively inexpensive, allowing the procedure to be performed on a wide variety of patients.
There, I thought I could make use of the knowledge of thoracic surgery that I had studied and researched.
After researching past papers and studies, we learned that a treatment was once used in the U.S., in which a net was placed over the heart to prevent it from dilating. Unfortunately, this treatment has several problems and has not been put into practical use in the present day.
However, we found the "net covering the heart" to be effective and began full-scale research in 2005 to create a product that would eliminate these problems.
For the treatment of dilated cardiomyopathy.
Safe and effective optionindicates object of desire, like, hate, etc.
Research and development related to cardiac assist nets was a continuous process of trial and error in the beginning. Each time we made a prototype, we would pursue the problem, try a new prototype, and repeat the process countless times....
I was fortunate to have the support of many people in various fields, including patients who participated in my clinical research.
With their support, Cardiac Assist Net is becoming one form of research and development of "a new and effective treatment to prevent the worsening of dilated cardiomyopathy.
We will continue our research and development to bring an effective treatment to as many patients with dilated cardiomyopathy as possible as soon as possible. We look forward to your continued support.
